With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the launch of its new high-precision Polystyrene Cell Viability Standards. These microspheres can provide researchers and laboratory professionals with reliable and highly reproducible tools in biological cell controls for instrument calibration and assay validation.
CD Bioparticles...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has today announced the launch of its comprehensive OMV-Based Bacterial Vaccines Development services. This new platform that integrates synthetic biology with advanced bacterial genome editing can address the historical limitations of traditional vaccine platforms, offering...
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the launch of its custom Enzyme-Conjugated Particles synthesis services. These particles are primarily polymer- and inorganic-based, and biomolecules and enzymes can be conjugated to them in different ratios for various applications.
Due to their unique specificity and high activity, enzymes...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a deeper understanding of tumor-stromal interactions and the development of more effective cancer therapies.
Although...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its enhanced, one-stop AAV Vector Design services to support researchers in accelerating advancements in gene therapy and delivery, including the design, construction, and cloning of custom Adeno-Associated Virus (AAV) vectors, as well as professional virus packaging...
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the launch and expanded availability of its cutting-edge Beads Based Multiplex Assay services for researchers to simultaneously measure up to 500 analytes from a single sample, significantly enhancing the efficiency and precision of preclinical and clinical research.
Measuring soluble...
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced its custom nucleic acid delivery particle synthesis services for the advancement of gene therapy, gene editing, vaccines and immunotherapy. These new offerings, such as the synthesis of basic particles, can address the growing need for safe and efficient delivery of gene therapy materials.
CD...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of a comprehensive range of exosome modification products and services to support researchers in harnessing the unique potential of exosomes for targeted drug delivery, diagnostics, and advanced therapeutic applications.
Exosomes are used as natural drug delivery...
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces the the expansion of its graphene product line with various layers and sizes, including functional graphene, graphene oxide, graphene nanoplatelets and graphene dispersion. This expansion underscores the company's commitment to providing high-quality graphene materials tailored to the evolving...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, continues to expand its portfolio by launching a new line of research products for Exosome Identification (WB markers), including the Exosomal Marker CD63 Antibody Set Kit, Exosomal Marker CD81 Antibody Set Kit, and Exosomal Marker CD9 Antibody Set Kit. This expanded portfolio offers...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek